This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Fresenius Medical Care Deutschland Gmbh. Active years: 2015-2018.
Company Filing History:
Years Active: 2015-2018
Title: Innovations by Pascal Werner
Introduction
Pascal Werner is an accomplished inventor based in Uechtelhausen, Germany. He has made significant contributions to the field of medical technology, particularly in the area of extracorporeal blood treatment. With a total of 2 patents to his name, Werner's work focuses on improving the efficiency and safety of blood treatment processes.
Latest Patents
Werner's latest patents include an "Apparatus for extracorporeal blood treatment and method for monitoring the fluid flow of an extracorporeal blood treatment apparatus." This invention addresses the critical need for monitoring fluid flow during blood treatment by utilizing a collection container to track changes in weight during filling or rinsing phases. This continuous monitoring enhances the safety and effectiveness of blood treatment procedures. Another notable patent is the "Method as well as apparatuses for retrograde filling of at least one calcium line of an extracorporeal blood circuit." This invention provides a method for priming a line that adds a medical solution, specifically targeting calcium lines in blood circuits, and includes a control device for regulating the process.
Career Highlights
Throughout his career, Pascal Werner has worked with prominent companies in the medical field, including Fresenius Medical Care Deutschland GmbH. His experience in these organizations has allowed him to develop innovative solutions that address critical challenges in medical technology.
Collaborations
Werner has collaborated with notable professionals in his field, including Olaf Kessel-Deynet and Josef Beden. These partnerships have contributed to the advancement of his inventions and the overall improvement of medical treatment technologies.
Conclusion
Pascal Werner's contributions to the field of medical technology through his patents and collaborations highlight his commitment to innovation in extracorporeal blood treatment. His work continues to impact the medical community positively, ensuring safer and more effective treatment options for patients.